My reseasrch focuses on leveraging the gut microbiota and host signalling of gut microbiota-derived metabolites to develop innovative treatments for hypertension and other cardiovascular diseases. I am 1.5 years post-PhD and ranked among the top 5 most published Australian researchers in gut microbiota (T.8040, SciVal), all in cardiovascular research. I have secured AUD 328K in competitive funding as a CI from the Heart Foundation (AUD 150,000) and the Australian Stroke and Heart Research Accelerator (AUD 158,000), along with sole CI grant from the Foundation of High Blood Pressure Research (AUD 20,000). I have published 19 papers, including 8 first-author publications, with >500 citations (5 publications with >50 citations), h-index 9, FWCI 2.6. My work has appeared in top journals like European Heart Journal, Circulation Research, Cardiovascular Research, and Hypertension, with one paper featured on a journal cover and achieving top 5-percent attention scores. I have led initiatives nationally and internationally, holding roles such as postdoctoral representative (local), Victorian Cardiovascular Research Network Rising Stars Sub-Committee (state), chair of the Hypertension Australia Early Career Researchers Committee (national), and member of the ISH New Investigator Committee (international). I have been a finalist for 17 awards, winning 12 (total value AUD 25k). Notable recognitions include the Ralph Reader Prize (Cardia Society of Australia and New Zealand) and the ISH New Investigator Award.